Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 3/2010

Open Access 01-03-2010 | Original Article

Delay in Diagnostic Workup and Treatment of Esophageal Cancer

Authors: Brechtje A. Grotenhuis, Pieter van Hagen, Bas P. L. Wijnhoven, Manon C. W. Spaander, Hugo W. Tilanus, Jan J. B. van Lanschot

Published in: Journal of Gastrointestinal Surgery | Issue 3/2010

Login to get access

Abstract

Introduction

Esophageal cancer should preferably be detected and treated at an early stage, but this may be prohibited by late onset of symptoms and delays in referral, diagnostic workup, and treatment. The aim of this study was to investigate the impact of these delays on outcome in patients with esophageal cancer.

Methods

For 491 patients undergoing esophagectomy for cancer between 1991 and 2007, patients’ short- and long-term outcome were analyzed according to different time intervals between onset of symptoms, diagnosis, and surgical treatment.

Results

Length of prehospital delay (from onset of symptoms until endoscopic diagnosis) did not affect patient’s short- or long-term outcome. A shorter hospital delay between establishing the diagnosis of esophageal cancer on endoscopy and surgery was associated with lower overall morbidity and in-hospital mortality. Patients of ASA classes I and II experienced a shorter hospital delay than patients of ASA classes III and IV. Length of hospital delay between endoscopic diagnosis and surgery did not affect pathological tumor–node–metastasis stage or R0-resection rate. Longer hospital delay did not result in worse survival: Overall survival after esophagectomy for cancer was not significantly different between patients with hospital delay <5, 5–8, or >8 weeks (24.7%, 21.7%, and 32.3%, respectively; p = 0.12).

Conclusion

A longer hospital delay (between endoscopic diagnosis and surgery) resulted in worse patient’s short-term outcome (higher overall morbidity and mortality rates) but not in a worse long-term outcome (overall survival). This may be explained by a more time-consuming diagnostic workup in patients with a poorer physical status and not by tumor progression.
Literature
1.
go back to reference Lerut T, De Leyn P, Coosemans W et al. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992;216(5):583–590.CrossRefPubMed Lerut T, De Leyn P, Coosemans W et al. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992;216(5):583–590.CrossRefPubMed
2.
go back to reference Siewert JR, Stein HJ, Feith M et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001;234(3):360–367. (discussion 368–369).CrossRefPubMed Siewert JR, Stein HJ, Feith M et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001;234(3):360–367. (discussion 368–369).CrossRefPubMed
3.
go back to reference Hulscher JB, van Sandick JW, de Boer AG et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347(21):1662–1669.CrossRefPubMed Hulscher JB, van Sandick JW, de Boer AG et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347(21):1662–1669.CrossRefPubMed
4.
go back to reference Eloubeidi MA, Desmond R, Arguedas MR et al. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002;95(7):1434–1443.CrossRefPubMed Eloubeidi MA, Desmond R, Arguedas MR et al. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002;95(7):1434–1443.CrossRefPubMed
5.
go back to reference Wijnhoven BP, Tran KT, Esterman A et al. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 2007;245(5):717–725.CrossRefPubMed Wijnhoven BP, Tran KT, Esterman A et al. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 2007;245(5):717–725.CrossRefPubMed
6.
go back to reference Richards MA, Westcombe AM, Love SB et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999;353(9159):1119–1126.CrossRefPubMed Richards MA, Westcombe AM, Love SB et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999;353(9159):1119–1126.CrossRefPubMed
7.
go back to reference Ramos M, Esteva M, Cabeza E et al. Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer 2007;43(17):2467–2478.CrossRefPubMed Ramos M, Esteva M, Cabeza E et al. Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer 2007;43(17):2467–2478.CrossRefPubMed
8.
go back to reference Ramos M, Esteva M, Cabeza E et al. Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer. Eur J Cancer 2008;44(4):510–521.CrossRefPubMed Ramos M, Esteva M, Cabeza E et al. Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer. Eur J Cancer 2008;44(4):510–521.CrossRefPubMed
9.
go back to reference Wang J, Liu F, Gao H et al. The symptom-to-treatment delay and stage at the time of treatment in cancer of esophagus. Jpn J Clin Oncol 2008;38(2):87–91.CrossRefPubMed Wang J, Liu F, Gao H et al. The symptom-to-treatment delay and stage at the time of treatment in cancer of esophagus. Jpn J Clin Oncol 2008;38(2):87–91.CrossRefPubMed
10.
go back to reference Kotz BS, Croft S, Ferry DR. Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? A study based on West Midlands cancer registration data. Br J Cancer 2006;95(7):835–840.CrossRefPubMed Kotz BS, Croft S, Ferry DR. Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? A study based on West Midlands cancer registration data. Br J Cancer 2006;95(7):835–840.CrossRefPubMed
11.
go back to reference Rothwell JF, Feehan E, Reid I et al. Delay in treatment for oesophageal cancer. Br J Surg 1997;84(5):690–693.CrossRefPubMed Rothwell JF, Feehan E, Reid I et al. Delay in treatment for oesophageal cancer. Br J Surg 1997;84(5):690–693.CrossRefPubMed
12.
go back to reference Martin IG, Young S, Sue-Ling H, Johnston D. Delays in the diagnosis of oesophagogastric cancer: a consecutive case series. BMJ 1997;314(7079):467–470.PubMed Martin IG, Young S, Sue-Ling H, Johnston D. Delays in the diagnosis of oesophagogastric cancer: a consecutive case series. BMJ 1997;314(7079):467–470.PubMed
13.
go back to reference Witzig R, Schonberger B, Fink U et al. Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma. Endoscopy 2006;38(11):1122–1126.CrossRefPubMed Witzig R, Schonberger B, Fink U et al. Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma. Endoscopy 2006;38(11):1122–1126.CrossRefPubMed
14.
go back to reference Kok TC, Van Lanschot JJB, Siersema PD et al. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial. Proc Am Soc Clin Oncol 1997;17:984. Kok TC, Van Lanschot JJB, Siersema PD et al. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial. Proc Am Soc Clin Oncol 1997;17:984.
15.
go back to reference van Heijl M, van Lanschot JJ, Koppert LB et al. Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS). BMC Surg 2008;8:21.CrossRefPubMed van Heijl M, van Lanschot JJ, Koppert LB et al. Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS). BMC Surg 2008;8:21.CrossRefPubMed
16.
go back to reference Omloo JM, Lagarde SM, Hulscher JB et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 2007;246(6):992–1000. (discussion 1000–1001).CrossRefPubMed Omloo JM, Lagarde SM, Hulscher JB et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 2007;246(6):992–1000. (discussion 1000–1001).CrossRefPubMed
17.
go back to reference Sobin L. TNM classification of malignant tumors, 6th edn. Wiley: New York, 2002. Sobin L. TNM classification of malignant tumors, 6th edn. Wiley: New York, 2002.
18.
go back to reference Visser MR, van Lanschot JJ, van der Velden J et al. Quality of life in newly diagnosed cancer patients waiting for surgery is seriously impaired. J Surg Oncol 2006;93(7):571–577.CrossRefPubMed Visser MR, van Lanschot JJ, van der Velden J et al. Quality of life in newly diagnosed cancer patients waiting for surgery is seriously impaired. J Surg Oncol 2006;93(7):571–577.CrossRefPubMed
19.
go back to reference Logan RF, Behan MW, Campion G, Keating NA. Impact of the two-week referral guideline on time to diagnosis and treatment in oesophago-gastric cancer. Clin Med 2003;3(4):386–387.PubMed Logan RF, Behan MW, Campion G, Keating NA. Impact of the two-week referral guideline on time to diagnosis and treatment in oesophago-gastric cancer. Clin Med 2003;3(4):386–387.PubMed
20.
go back to reference Spahos T, Hindmarsh A, Cameron E et al. Endoscopy waiting times and impact of the two week wait scheme on diagnosis and outcome of upper gastrointestinal cancer. Postgrad Med J 2005;81(961):728–730.CrossRefPubMed Spahos T, Hindmarsh A, Cameron E et al. Endoscopy waiting times and impact of the two week wait scheme on diagnosis and outcome of upper gastrointestinal cancer. Postgrad Med J 2005;81(961):728–730.CrossRefPubMed
21.
go back to reference Rachet B, Maringe C, Nur U et al. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol 2009;10(4):351–369.CrossRefPubMed Rachet B, Maringe C, Nur U et al. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol 2009;10(4):351–369.CrossRefPubMed
Metadata
Title
Delay in Diagnostic Workup and Treatment of Esophageal Cancer
Authors
Brechtje A. Grotenhuis
Pieter van Hagen
Bas P. L. Wijnhoven
Manon C. W. Spaander
Hugo W. Tilanus
Jan J. B. van Lanschot
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 3/2010
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-009-1109-y

Other articles of this Issue 3/2010

Journal of Gastrointestinal Surgery 3/2010 Go to the issue